AZ-33

CAS No. 1370290-34-8

AZ-33( AZ-33 | AZ 33 | AZ33 | LDHA Inhibitor 33 )

Catalog No. M17263 CAS No. 1370290-34-8

AZ-33 is an LDHA inhibitor. Binding affinity to 6-His-tagged human LDHA (2 to 322 amino acid residue) expressed in Escherichia coli BL21 (DE3) cells by SPR analysis with an active value of 0.093 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 92 In Stock
10MG 155 In Stock
25MG 302 In Stock
50MG 445 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AZ-33
  • Note
    Research use only, not for human use.
  • Brief Description
    AZ-33 is an LDHA inhibitor. Binding affinity to 6-His-tagged human LDHA (2 to 322 amino acid residue) expressed in Escherichia coli BL21 (DE3) cells by SPR analysis with an active value of 0.093 μM.
  • Description
    AZ-33, also known as LDHA Inhibitor 33, is a LDHA Inhibitor. Lactate dehydrogenase A (LDHA), a key enzyme involved in anaerobic glycolysis, is frequently deregulated in human malignancies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AZ-33 | AZ 33 | AZ33 | LDHA Inhibitor 33
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    LDHA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1370290-34-8
  • Formula Weight
    497.56
  • Molecular Formula
    C25H27N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (200.98 mM)
  • SMILES
    O=C(O)C(C(=O)O)Cc1ccc(cc1)CCCC(=O)NCCC(=O)Nc1ccc2c(c1)sc(n2)C
  • Chemical Name
    2-(4-(4-((3-((2-Methylbenzo[d]thiazol-6-yl)amino)-3-oxopropyl)amino)-4-oxobutyl)benzyl)malonic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ward RA, et al.J Med Chem. 2012 Apr 12;55(7):3285-306.
molnova catalog
related products
  • VU 0285683

    VU 0285683 is a specific negative allosteric modulator of mGluR5 with a high affinity for the MPEP binding site. VU 0285683 shows anxiolytic-like activity.

  • GYKI 52466 dihydroch...

    GYKI 52466 dihydrochloride (GYKI 52466 2HCl) is a highly potent, orally active and selective AMPA/Kainate receptor antagonist with good blood-brain permeability and anticonvulsant activity that can be used to study neurological diseases such as Parkinson's and epilepsy.

  • Fangchinoline

    Fangchinoline is extracted from Stephania tetrandra S. Moore.